Ignite Creation Date:
2025-12-24 @ 5:13 PM
Ignite Modification Date:
2026-02-25 @ 5:49 PM
Study NCT ID:
NCT01114750
Status:
SUSPENDED
Last Update Posted:
2010-10-05
First Post:
2010-04-29
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study to Determine the Absorption of Peroral Insulin in Dextran Matrix (ORA3)
Sponsor:
Bows Pharmaceuticals AG
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
ORA3-2010-019098-14
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Nabil Al-Tawil
Old Organization:
Karolinska Trial Alliance